Organon (OGN) Income towards Parent Company (2020 - 2026)

Organon (OGN) recorded quarterly Income towards Parent Company of $146.0 million in Q1 2026, up 171.22% quarter-over-quarter from -$205.0 million in Q4 2025, and up 67.82% on a YoY basis from $87.0 million in Q1 2025.

Organon (OGN) Income towards Parent Company (2020 - 2026) Analysis & Trends

Organon's Income towards Parent Company history runs 6 years deep, the most recent figure standing at $146.0 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 67.82% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $246.0 million (down 67.2% YoY), while the FY2025 annual figure was $187.0 million, down 78.36% from the prior year.
  • Income towards Parent Company was $146.0 million for Q1 2026 at Organon, up from -$205.0 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $546.0 million in Q4 2023 to a low of -$205.0 million in Q4 2025.
  • Historically, Income towards Parent Company has averaged $170.8 million across 4 years, with a median of $160.0 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company jumped 518.97% in 2024, then sank 288.07% in 2025.
  • A 4-year view of Income towards Parent Company shows it stood at $546.0 million in 2023, then plunged by 80.04% to $109.0 million in 2024, then tumbled by 288.07% to -$205.0 million in 2025, then jumped by 171.22% to $146.0 million in 2026.
  • The last three Income towards Parent Company figures came in at $146.0 million (Q1 2026), -$205.0 million (Q4 2025), and $160.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,162,528.78 Bn 93,162,523.82 Bn 7.76 Bn
2 Eli Lilly 1,017.87 Bn 1,012.58 Bn 16.22 Bn
3 Johnson & Johnson 575.51 Bn 553.46 Bn 15.96 Bn
4 AbbVie 400.43 Bn 391.08 Bn 10.78 Bn
5 Merck 294.19 Bn 288.54 Bn 12.09 Bn
6 Amgen 182.41 Bn 170.37 Bn 5.87 Bn
7 Gilead Sciences 150.97 Bn 143.24 Bn 5.52 Bn
8 Pfizer 145.75 Bn 132.97 Bn -1.21 Bn
9 Bristol Myers Squibb 113.35 Bn 102.90 Bn 8.07 Bn
10 Organon 3.48 Bn 2.37 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.00 Mn
Dec 31, 2025 -205.00 Mn
Sep 30, 2025 160.00 Mn
Jun 30, 2025 145.00 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 109.00 Mn
Sep 30, 2024 359.00 Mn
Jun 30, 2024 195.00 Mn
Mar 31, 2024 201.00 Mn
Dec 31, 2023 546.00 Mn
Sep 30, 2023 58.00 Mn
Jun 30, 2023 242.00 Mn
Mar 31, 2023 177.00 Mn
Jun 30, 2021 -4.00 Mn
Mar 31, 2021 4.00 Mn
Dec 31, 2020 -8.00 Mn
Sep 30, 2020 -13.00 Mn
Jun 30, 2020 -44.00 Mn
Mar 31, 2020 -31.00 Mn